Veritable’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,632
| Closed | -$852K | – | 235 |
|
2023
Q2 | $852K | Buy |
6,632
+681
| +11% | +$87.5K | 0.01% | 401 |
|
2023
Q1 | $691K | Buy |
5,951
+554
| +10% | +$64.4K | 0.01% | 453 |
|
2022
Q4 | $611K | Buy |
5,397
+569
| +12% | +$64.4K | 0.01% | 470 |
|
2022
Q3 | $389K | Buy |
4,828
+201
| +4% | +$16.2K | 0.01% | 563 |
|
2022
Q2 | $345K | Sell |
4,627
-929
| -17% | -$69.3K | 0.01% | 632 |
|
2022
Q1 | $711K | Buy |
5,556
+280
| +5% | +$35.8K | 0.01% | 468 |
|
2021
Q4 | $708K | Buy |
5,276
+1,108
| +27% | +$149K | 0.01% | 472 |
|
2021
Q3 | $570K | Buy |
4,168
+52
| +1% | +$7.11K | 0.01% | 505 |
|
2021
Q2 | $439K | Buy |
4,116
+760
| +23% | +$81.1K | 0.01% | 570 |
|
2021
Q1 | $302K | Sell |
3,356
-104
| -3% | -$9.36K | 0.01% | 656 |
|
2020
Q4 | $320K | Sell |
3,460
-804
| -19% | -$74.4K | 0.01% | 607 |
|
2020
Q3 | $439K | Buy |
4,264
+244
| +6% | +$25.1K | 0.01% | 483 |
|
2020
Q2 | $407K | Buy |
4,020
+376
| +10% | +$38.1K | 0.01% | 514 |
|
2020
Q1 | $245K | Sell |
3,644
-304
| -8% | -$20.4K | 0.01% | 614 |
|
2019
Q4 | $216K | Buy |
+3,948
| New | +$216K | ﹤0.01% | 765 |
|